Dopamine D2 receptor dimers and receptor-blocking peptides

被引:233
作者
Ng, GYK
ODowd, BF
Lee, SP
Chung, HT
Brann, MR
Seeman, P
George, SR
机构
[1] UNIV TORONTO,DEPT PSYCHIAT,TORONTO,ON M5S 1A8,CANADA
[2] UNIV TORONTO,DEPT MED,TORONTO,ON M5S 1A8,CANADA
[3] ADDICT RES FDN,TORONTO,ON M5S 2S1,CANADA
[4] UNIV VERMONT,SCH MED,DEPT PSYCHIAT,BURLINGTON,VT 05405
[5] UNIV VERMONT,SCH MED,DEPT PHARMACOL,BURLINGTON,VT 05405
基金
英国医学研究理事会;
关键词
D O I
10.1006/bbrc.1996.1489
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dopamine D2 receptors exist as dimers in whole cell lysate, crude membranes prepared from human caudate, and following solubilization and immunoprecipitation of the receptor from these tissues. Photoaffinity labelling experiments confirmed that D2 receptors exist either as monomers that are selective targets for spiperone or as dimers that are targets for nemonapride. incubation of D2 dimers with peptides derived from the putative transmembrane (TM) domains of the D2 receptor, or incubation under high temperatures or low pH resulted in the dissociation of the dimer to monomer. D2-TM peptides were unable to dissociate dopamine D1 and serotonin 5-HT1B receptor dimers, suggesting that receptor dimers are formed by specific intermolecular noncovalent interactions involving TM regions. This opens a path to new selective therapeutic receptor-blocking compounds based on this principle of mimicking transmembrane portions of neurotransmitter receptors. (C) 1996 Academic Press, Inc.
引用
收藏
页码:200 / 204
页数:5
相关论文
共 11 条
  • [1] VARIABILITY IN D-2-DOPAMINE RECEPTOR DENSITY AND AFFINITY - A PET STUDY WITH [C-11] RACLOPRIDE IN MAN
    FARDE, L
    HALL, H
    PAULI, S
    HALLDIN, C
    [J]. SYNAPSE, 1995, 20 (03) : 200 - 208
  • [2] FARDE L, 1990, ARCH GEN PSYCHIAT, V47, P213
  • [3] LOCALIZATION OF D(1) AND D(2) DOPAMINE-RECEPTORS IN BRAIN WITH SUBTYPE-SPECIFIC ANTIBODIES
    LEVEY, AI
    HERSCH, SM
    RYE, DB
    SUNAHARA, RK
    NIZNIK, HB
    KITT, CA
    PRICE, DL
    MAGGIO, R
    BRANN, MR
    CILIAX, BJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) : 8861 - 8865
  • [4] COEXPRESSION STUDIES WITH MUTANT MUSCARINIC ADRENERGIC-RECEPTORS PROVIDE EVIDENCE FOR INTERMOLECULAR CROSS-TALK BETWEEN G-PROTEIN-LINKED RECEPTORS
    MAGGIO, R
    VOGEL, Z
    WESS, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) : 3103 - 3107
  • [5] NG GYK, 1994, J NEUROCHEM, V63, P1589
  • [6] DESENSITIZATION, PHOSPHORYLATION AND PALMITOYLATION OF THE HUMAN DOPAMINE-D1 RECEPTOR
    NG, GYK
    MOUILLAC, B
    GEORGE, SR
    CARON, M
    DENNIS, M
    BOUVIER, M
    ODOWD, BF
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 267 (01): : 7 - 19
  • [7] HUMAN SEROTONIN(1B) RECEPTOR EXPRESSION IN SF9 CELLS - PHOSPHORYLATION, PALMITOYLATION, AND ADENYLYL-CYCLASE INHIBITION
    NG, GYK
    GEORGE, SR
    ZASTAWNY, RL
    CARON, M
    BOUVIER, M
    DENNIS, M
    ODOWD, BF
    [J]. BIOCHEMISTRY, 1993, 32 (43) : 11727 - 11733
  • [8] NO ELEVATED D-2 DOPAMINE-RECEPTORS IN NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS REVEALED BY POSITRON EMISSION TOMOGRAPHY AND [C-11] N-METHYLSPIPERONE
    NORDSTROM, AL
    FARDE, L
    ERIKSSON, L
    HALLDIN, C
    [J]. PSYCHIATRY RESEARCH-NEUROIMAGING, 1995, 61 (02) : 67 - 83
  • [9] PEARLSON GD, 1995, ARCH GEN PSYCHIAT, V52, P471
  • [10] DOPAMINE D-2 RECEPTOR DENSITY ESTIMATES IN SCHIZOPHRENIA - A POSITRON EMISSION TOMOGRAPHY STUDY WITH C-11 N-METHYLSPIPERONE
    TUNE, LE
    WONG, DF
    PEARLSON, G
    STRAUSS, M
    YOUNG, T
    SHAYA, EK
    DANNALS, RF
    WILSON, AA
    RAVERT, HT
    SAPP, J
    COOPER, T
    CHASE, GA
    WAGNER, HN
    [J]. PSYCHIATRY RESEARCH, 1993, 49 (03) : 219 - 237